Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

The last decade has seen numerous outbreaks of Clostridium difficile-associated disease (CDAD), which presented significant challenges for healthcare facilities worldwide. We have identified and purified thuricin CD, a two-component antimicrobial that shows activity against C. difficile in the nanom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rea, Mary C., Sit, Clarissa S., Clayton, Evelyn, O'Connor, Paula M., Whittal, Randy M., Zheng, Jing, Vederas, John C., Ross, R. Paul, Hill, Colin
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2010
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889069/
https://ncbi.nlm.nih.gov/pubmed/20435915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0913554107
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares